Biocytogen will participate in BIO Partnering™ @JPM Week 2026, taking place January 12–15 in San Francisco, where our business development and licensing team will be available for strategic meetings. During JPM Week, we will highlight our fully human antibody discovery platforms, enabled by proprietary RenMice® technologies, which support the efficient generation of high-quality, developable therapeutic antibodies across multiple modalities. Our integrated capabilities are designed to advance antibody programs from early discovery through IND-enabling studies, helping partners accelerate development timelines and reduce early-stage risk.
What is Bio Partnering JPM Week 2026?
JPM Week refers to the week of January 12–15, 2026, when the biotechnology and investment community gathers in San Francisco for networking, deal-making, and meetings surrounding the annual J.P. Morgan Healthcare Conference. If you have questions about the J.P. Morgan Healthcare Conference itself, please contact J.P. Morgan directly.
Event Overview
Date: January 12th-15th, 2025
Venue: San Francisco Marriott Marquis.780 Mission Street, San Francisco, CA 94103
Event Schedule
For more information, please refer to Bio Partnering JPM Week 2026 info.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We can’t wait to see you in San Francisco, CA!
